Predian in the complex treatment of patients with diabetes mellitus
- Authors: Grigorieva I.V.
- Issue: Vol 69, No 4 (1988)
- Pages: 295-296
- Section: Articles
- URL: https://journals.rcsi.science/kazanmedj/article/view/99687
- DOI: https://doi.org/10.17816/kazmj99687
- ID: 99687
Cite item
Full Text
Abstract
The aim of this work was to study the effectiveness of predian (sulfonamide developed at the Research Institute Servier, France) as a sugar-lowering agent, as well as its effect on the coagulation and antiplatelet systems of diabetic patients.
Keywords
Full Text
##article.viewOnOriginalSite##About the authors
I. V. Grigorieva
Author for correspondence.
Email: info@eco-vector.com
Russian Federation
References
Supplementary files
